Your browser doesn't support javascript.
loading
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
Pergaris, Alexandros; Stefanou, Dimitra; Keramari, Panagiota; Sousouris, Stylianos; Kavantzas, Nikolaos; Gogas, Helen; Mikou, Panagiota.
Afiliación
  • Pergaris A; Department of Cytopathology, Laiko Hospital, 11527 Athens, Greece.
  • Stefanou D; First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Keramari P; First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
  • Sousouris S; Department of Cytopathology, Laiko Hospital, 11527 Athens, Greece.
  • Kavantzas N; Department of Cytopathology, Laiko Hospital, 11527 Athens, Greece.
  • Gogas H; First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Mikou P; First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
Diagnostics (Basel) ; 11(12)2021 Nov 28.
Article en En | MEDLINE | ID: mdl-34943460
ABSTRACT
The International System for Reporting Serous Fluid Cytopathology (TIS) classifies serous effusions into five categories non-diagnostic (ND), negative for malignancy (NFM), atypia of unknown significance (AUS), suspicious for malignancy (SFM) and malignant (MAL). The main objectives of this classification comprise the establishment of a universal code of communication between cytopathologists and clinicians and histopathologists, as well as between different laboratories worldwide, paving the way for the setting of clinical management guidelines based on the risk of malignancy assessment for each diagnostic category. We retrieved the total number of pleural and peritoneal effusion cases of our department for the three-year time period between 2018 and 2020, yielding a total of 528 and 500 cases, respectively. We then proceeded to reclassify each specimen according to TIS guidelines and calculate the risk of malignancy (ROM) for each category by searching each patients' histology records, medical history and clinical follow-up. For pleural effusions, 3 (0.57%) cases were classified as ND, 430 (81.44%) cases as NFM, 15 (2.84%) as AUS, 15 (2.84%) as SFM and 65 (12.31%) as MAL. ROM amounted to 0%, 5.3%, 33.33%, 93.33% and 100% for each category, respectively. As far as peritoneal effusions are concerned, 6 (1.2%) were categorized as ND with ROM estimated at 16.66%, 347 (69.4%) as NFM (ROM = 9%), 13 (2.6%) as AUS (ROM = 38.46%), 12 (2.4%) as SFM (ROM = 83.33%) and 122 (24.4%) as MAL (ROM = 100%). Our results underline the utility of the current classification, both as a means of communication between doctors of different specialties and as general guidelines for the further clinical management of patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Grecia